Acdal, Devinjan B.

HRN: 02-16-61  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/03/2023
CEFTRIAXONE 1G (VIAL)
01/03/2023
01/09/2023
IVT
2gms
Od
Cap Mr
Waiting Final Action 
01/07/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
01/07/2023
01/14/2023
IVT
1.5gms
Q8
Cap Mr, Ba In Ae
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: